Although MYC amplification promotes aggressive breast cancer phenotype [7, 16, 21, 38], whether ATR and ATM expressions influence pathology and clinical outcomes in MYC overexpressed breast cancers is unknown. This evidence concerns the gene ATR and breast carcinoma.